As of 3:59pm ET
| +0.1025 / +17.82%|
The 1 analysts offering 12-month price forecasts for Celularity Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +268.95% increase from the last price of 0.68.
The current consensus among 2 polled investment analysts is to Buy stock in Celularity Inc. This rating has held steady since May, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.